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SALIVARY CORTISOL AS A MEASURE OF STRESS REACTIVITY IN 
ADOLESCENTS WITH PSYCHIATRIC DISORDERS. CORTLYN BROWN AND 
KATHLEEN MERIKANGAS. NATIONAL INSTITUTES OF MENTAL HEALTH, 
BETHESDA, MD (SPONSORED BY ANDRES MARTIN, YALE CHILD STUDY 
CENTER). 
ABSTRACT	  
Objective: The aims of this study were to 1) examine salivary cortisol distributions in a 
nationally representative sample of U.S. adolescents; and to 2) evaluate whether youth 
with mood and anxiety disorders are associated with differential salivary cortisol 
response to an acute mild stressor.  
 
Background: An association between mood disorders and hypothalamic-pituitary-adrenal 
(HPA) axis dysfunction, as indicated by elevated levels of cortisol, has been well 
established [1, 2]. Although studies have suggested that these differences emerge early in 
the development of mood disorders in children and adolescents [3] the samples have 
generally been very small and primarily derived from clinical settings [3-5]. 
 
Methods: The National Comorbidity Survey-Adolescent Supplement (NCS-A) is a 
nationally representative face-to-face interview of adolescents aged 13-18 years in the 
continental U.S. [6]. Adolescents were administered a modified version of the World 
Health Organization Composite International Diagnostic Interview Version 3.0 and saliva 
was collected pre- and post- interview on a subset of 1,755 adolescents. Quantile 
regression models were used to assess pre- interview cortisol and rate of change in 
salivary cortisol level across entire quantile distributions adjusted for time of day cortisol 
	   5	  
sample collected, sex, age, and additionally pre-interview cortisol level when rate of 
change in cortisol was used as the outcome variable. For descriptive purpose, traditional 
linear regression analyses were performed in parallel.  
 
Results: Pre-interview cortisol levels were higher in the morning and decreased over the 
time of day.	  The magnitude of rate of change in cortisol measures was greater in the 
earlier time categories than that in the later time categories.  After adjustment for time of 
cortisol sample collected, pre-interview cortisol levels were significantly lower across 
quantile distributions in the younger age groups (13-14y, 15-16y) compared to the oldest 
(17-18y), and were higher among adolescents with lower family income around the lower 
quantile range. There were no sex differences in pre-interview cortisol levels, but the rate 
of change was significantly smaller at the lower end of quantile distribution among 
females than that in males. Across the majority of quantile distributions, adolescents with 
earlier weekday bedtime and mid-sleep time were significantly associated with lower pre-
interview cortisol level as well as rate of change compared to those with later bedtime 
and delayed mid-time sleep. Although suicidality was not associated with pre-interview 
cortisol level, there was a greater rate of change in cortisol among adolescents with 
suicidal behavior. Anxiety status was not associated with pre-interview cortisol level, 
while adolescents with lifetime mood disorders had somewhat lower pre-interview 
cortisol level at the lower end of quantile distribution. With respect to rate of change in 
cortisol level, adolescents with either lifetime or 12-month anxiety disorders showed a 
greater rate of change than those without disorders at the lower quantile distributions. 
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Those with severe anxiety and those with 12-month mood disorders had a greater rate of 
changes in cortisol levels than controls.  
 
Conclusions: Our findings reveal that adolescents with mood and/or anxiety disorders 
have a greater change in salivary cortisol before and after a diagnostic interview as an 
acute mild stressor compared to their non-anxious or depressed counterparts. These 
findings provide biologic evidence for greater stress reactivity in adolescents with anxiety 
and depression in non-clinical samples. 
 
Disclosures: Nothing to disclose. 
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INTRODUCTION	  
Literature has estimated the lifetime prevalence of adolescent mood disorders to 
be 14.3% [6]. It is known that adult mood disorders are associated with a stress response 
physiologically represented by hypothalamic-pituitary-adrenal (HPA) axis abnormalities. 
When the body encounters stress, the hypothalamus produces corticotropin-releasing 
hormone (CRH), which stimulates the anterior pituitary to release adrenocorticotropic 
hormone (ACTH). ACTH then stimulates the adrenal cortex to produce glucocorticoids 
such as cortisol. The glucocorticoids serve as negative feedback and suppress ACTH 
production by the hypothalamus.  
HPA hyperactivity-induced elevated cortisol, as well as a blunted response to the 
dexamethasone suppression test (DST), have been observed in adult depression. In this 
test, dexamethasone, an exogenous hormone that mimics cortisol, stimu[7]lates a 
hypercortisolic environment and exerts negative feedback on the hypothalamus [8-10]. 
Other studies found that adult depression was associated with a hypocortisolism state 
potentially resulting from HPA axis exhaustion secondary to chronic depressive episodes 
[11, 12]. Similarly, adult bipolar disease has been associated with both relative 
hypocortisolism and relative hypercortisolism [13].  
A consensus has yet to be reached as to the relationship between cortisol and adult 
anxiety disorders. In a study of elderly individuals, diurnal cortisol was up-regulated in 
GAD or phobic disorder [5, 14]. It has also been shown that adults with GAD have lower 
cortisol awakening response [15].   
As with adult studies, there is a lack of consensus on the relationship between 
cortisol and adolescent mood and anxiety disorders. Furthermore, many of these studies 
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have been limited by small sample sizes [4, 5] and the invasiveness of collecting serum 
samples to test for cortisol. In addition, most adolescent cortisol studies are not 
population based and instead draw from clinical samples. As these cohorts are limited to 
those that present to clinic, moderate to severe clinical presentations are frequently 
overrepresented. Lastly, the majority of studies have used laboratory stimuli (either 
administration of corticotropin-releasing hormone or dexamethasone) that are subject to a 
large number of false-positives and false-negatives [16]. A second shortcoming with 
laboratory stressors is that the results cannot be extrapolated to stress reactivity in the 
everyday lives of the children. The present study was motivated the address these 
disadvantages.  
The National Comorbidity Survey-Adolescent Supplement (NCS-A) consists of a 
nationally representative, ethnically diverse sample of adolescents in the United States. 
As we utilized salivary cortisol rather than serum, we were able to obtain cortisol 
measurements for 1,755 of the adolescents who have complete information on the full 
Composite International Diagnostic Interview, making it the largest sample of cortisol in 
U.S. children or adolescents.   
Salivary cortisol has been shown to be a direct representation of unbound serum 
cortisol. In addition, salivary cortisol more accurately reflects acute cortisol changes than 
serum [17]. Of the few studies that exist, elevated levels of cortisol were observed in 
adolescent depression [3, 18-21]. Prospective longitudinal studies, however, found no 
association between elevated salivary cortisol and risk of subsequent depression in 
adolescents [21].  
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In regards to adolescent bipolar disorder, Cervantes et al. concluded that there was 
no significant difference in the degree of hypersecretion of cortisol between the 
depressive and manic phases [22]. Whereas some studies have found no association 
between cortisol and adolescent anxiety disorders [23], others have found positive 
associations that were mediated by sex [24]. 
A further limitation of all previous studies on cortisol and adult or adolescent 
mood disorders is that they form estimates on the conditional mean of the response 
variable. This statistical method is poor when considering outliers in the response 
measurements. Furthermore, these studies are limited by only displaying one central 
tendency which may not accurately reflect and represent complex interactions.  Quantile 
regression, however, estimates quantiles of the response variable and, therefore, is a 
better model to consider outliers in response measurements. In addition, quantile 
regression allows for the analysis of different measures of central tendency for each 
quantile.   
Although quantile regression coefficients are interpreted the same way linear 
regression coefficients are, while linear regression posits the question, “What is the 
relation between X and Y?” quantile regression extends this to, “For whom does a 
relation between X and Y exist?'” as well as testing, “For whom is the relation stronger or 
weaker?" By using quantile regression, we have been able to model any point in the 
distribution of a continuous outcome variable. We present the first study to use quantile 
regression to analyze biomarkers of mood and anxiety disorders.  
This study has important implications for the screening, diagnosis, and treatment 
of mood and anxiety disorders across the lifespan. This study has the potential to identify 
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a biomarker that could screen high-risk pre-symptomatic adolescents leading to earlier 
intervention and preventative care. This is particularly important for bipolar youth as only 
half of this population receive mental health treatment [25, 26]. 
 The data from this study could also add a biological and laboratory component to 
the diagnosis of adolescent mood/anxiety disorders and aid in the identification of distinct 
syndromes within each of the mood/anxiety disorders. In addition, this data could provide 
information regarding the mechanism of adolescent mood/anxiety disorders. 
Furthermore, the research allows the study of comorbidity in mood disorders. Comorbid 
anxiety, for example, has been highly associated with mood disorders [27].  
 
SPECIFIC AIMS 
1) To examine the association between demographic and health related variables and 
adolescent cortisol levels.  
2) To determine if/how pre-interview salivary cortisol is altered in adolescents with 
mood and anxiety disorders when compared to healthy adolescent controls. 
3) To determine if/how stress reactivity in response to an acute minor stressor, as 
measured by change in salivary cortisol response, is altered in adolescents with 
mood and anxiety disorders when compared to healthy adolescent controls. 
4) To examine the effect that severity of mood and anxiety disorders have on 
adolescent cortisol levels.  
 
CORTISOL AND MAJOR DEPRESSION 
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Research on the role of HPA axis hyper/hypo-activation and cortisol in adolescent 
depression has been inconclusive. Differences have particularly emerged when 
comparing baseline measures compared to challenge studies of HPA axis by 
administration of dexamethasone or corticotropin releasing factor (CRF). In the 
dexamethasone suppression test, dexamethasone, an exogenous steroid similar in 
structure to cortisol, is given. In a hypercortisol (or hyperdexamethasone) environment, 
these two hormones exert negative feedback to the hypothalamus, which produces 
corticotrophin-releasing hormone (CRH). There is also negative feedback to the pituitary 
gland which, when activated, produces adrenocorticotropic hormone (ACTH).  
When given dexamethasone, adolescents with depression have less pituitary 
suppression and, therefore, higher levels of cortisol than healthy controls [18, 28]. This 
suggests that similar to adults, adolescents with depression have a decreased ability to 
regulate cortisol levels [18, 29]. Studies that have used an alternative test, CRH infusion, 
have failed to demonstrate a difference in cortisol response between depressed and 
healthy adolescents [30-32]. In the basal state, however, it has been shown that 
adolescents with depression have higher cortisol levels than control adolescents [3, 19-
21, 33].  
 
CORTISOL AND DYSTHYMIA 
Dysthymia is a mood disorder with behavioral and physical problems similar to 
depression. In dysthymia, however, the disease course is more chronic and symptoms are 
less severe; still, rates of suicide are comparable to major depressive disorder (MDD). 
Compared to major depression, there is even less known about the relationship between 
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cortisol and dysthymic adolescents. Of the few studies, Steward showed that early onset 
chronic atypical depression, similar to dysthymia, has lower afternoon cortisol and 
greater response to dexamethasone than late onset acute atypical depression [34]. In 
addition, Jansen et al concluded that dysthymic adolescents have a lower cortisol 
response to exercise induced stress than control subjects [35]. There is much more work 
that needs to be done with this subset of adolescent mood disorders.  
 
CORTISOL AND BIPOLAR 
Bipolar disorder is a mental health problem that ranges from extreme mood 
elevation during the manic states to severe sadness in the depressive periods. The role of 
cortisol in bipolar disorder is complex. Maripuu has shown that both relative 
hypocortisolism and relative hypercortisolism increase disease burden in bipolar adults 
[13]. Further understanding of the role of cortisol could lead to targeted therapies. 
Potential targets include leptin, lithium, and valproic acid. Each of these has been shown 
to decrease the effect of cortisol at the glucocorticoid receptor [36]. Roxanas published 
similar results and concluded that sodium valproate was able to reverse glucocorticoid 
induced mania [37].  
Another interesting area of research regarding bipolar disorder and cortisol is age 
of onset. It has been shown that cortisol is higher in subjects where age of onset is ≥ 30 
years than in those where age of onset is ≤ 30 years [38]. It is important to study this age 
relationship in adolescents as well. In general there is little cortisol research focused on 
adolescents with bipolar disorder. Of the adolescent research that exists, it has been 
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shown that offspring of bipolar parents have higher cortisol levels than those with non-
bipolar parents [39]. 
 
CORTISOL AND ANXIETY 
Similar to mood disorders, the research on the relationship between cortisol and 
anxiety disorders has been inconclusive. Female adolescents with generalized anxiety 
disorder (GAD) have been found to have elevated cortisol whereas no relationship was 
found between male adolescents with GAD and cortisol [24]. Other studies, however, 
have found associations between decreased hair cortisol and GAD but no association 
between salivary cortisol and GAD [40]. Panic disorder, another anxiety disorder, has 
been found to be associated with absent cortisol reactivity in response to the Trier Social 
Stress Test [41]. Studies examining a relationship between baseline plasma cortisol and 
panic disorder have been mixed with some showing a relationship between panic disorder 
and elevated cortisol [42] and others finding no such association [43].  
  
METHODS	  
Please	   note,	   the	   author	   of	   this	   thesis	   came	   up	   with	   the	   study	   question,	  
performed	  a	  complete	  literature	  review,	  conducted	  interviews,	  worked	  directly	  with	  a	  
statistician	  to	  perform	  the	  data	  analysis,	  and	  interpreted	  all	  results	  presented.	  
SAMPLE 
 The National Comorbidity Survey-Adolescent Supplement (NCS-A) is a 
nationally representative face-to-face interview of adolescents aged 13-18 years in the 
continental U.S. The survey used was very similar to the World Health Organization 
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(WHO) Composite International Diagnostic Interview Version 3.0 (CIDI) used in NCS-R 
(replication survey) modified for adolescents. Disorders with low prevalence in the 
adolescent population such as pathological gambling were removed. In addition, the 
language in the interview was made more kid friendly and contexts were changed to 
relate to the adolescent experience (e.g. work life to school life). The survey was carried 
out in a dual-frame sample that included a household and school subsample. The 
interview was administered face-to-face using laptop computer-assisted personal 
interviews (CAPI) in the adolescents’ homes by professional interviews based at the 
Survey Research Center of the Institute for Social Research at the University of 
Michigan. CAPI was used rather than paper-and-pencil because the interview contained 
many complex skips. In addition, CAPI is cost-effective with large sample sizes as 
programming costs are less than labor costs associated with reading the keypunch paper-
and-pencil responses.  
The adolescent response rate of the combined sub-samples was 82.9%.  Post-
stratification weighing corrected the minor differences in sample and population 
distributions on census sociodemographic variables and the school sample on school 
characteristics.  
One parent or guardian was asked to complete a self-administered questionnaire 
(PSAQ) about the participating adolescent’s developmental history and mental health.  
The professional staff of the Institute for Social Research at the University of Michigan 
administered the survey.  The Human Subjects Committees of Harvard Medical School 
and the University of Michigan approved the recruitment and consent procedures. 
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6,491 parents completed the full SAQ. Cases were then weighted for within-
household probability of selection variation and for any remaining differences between 
the sample and the US population on sociodemographic variables, including age, sex, 
race/ethnicity, parent education, urbanicity, poverty index ratio, marital status of parents 
and geography. The poverty index ratio was based on family size and the ratio of family 
income to the family’s poverty threshold level.  
It is important to note that although no prior study has used our clinical interview 
as an acute mild stressor, it is known that social stressors (e.g. having subjects give short 
speeches to an interviewer, background counting in public, etc.) are associated with an 
acute stress reaction and a related change in salivary cortisol [44]. Although anecdotal, 
many of our participants have had strong emotional reactions to the interview that have 
included crying, yelling, and leaving the room. Interview questions may be invasive and 
often prompt the respondent to relive traumatic events or think about triggers  (e.g. 
specific phobias). In addition, the face-to-face nature of the interview, particularly with a 
stranger, is likely to promote social anxiety. Studies have shown that subjects feel more 
comfortable reporting embarrassing behaviors, such as those asked in NCS-A, to audio 
computer-assisted self-administered interviews where there is no face-to-face contact 
with a stranger [45]. While we do not have ratings of our interview experience or anxiety, 
it follows that the novel situation of talking to the interviewer as well as the personal, and 
sometimes embarrassing, nature of the interview questions will induce a stress response 
particularly in adolescents. 
 
A random sample of 3,018 adolescents was selected from the full NCS-A set for 
earlier batches of salivary cortisol assay.  Our exclusion criteria included 1) extreme 
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outlying cortisol measures (n=2) 2) complete interview in more than 1 sitting (n=528); 3) 
no valid start and end interview time (same n=528); 4) interviews end time occurred 
before start time (n=9); 5) Interview start or end time too early (n=2); 6) diagnosis of 
asthma (potential for steroid medication) per child and/or parent report (n=542); 7) 
diagnosis of diabetes (n=26) per child report; 8) current smoking (n=184) per child 
report; 9) 12-month nicotine dependence (n=146) per child report; 10) 12-month drug 
abuse/dependence (n=161) per child report; 11) current pregnancy (n=10) per child 
report; 12) current prescription for contraceptive pills (n=114) per child report.  
After applying the exclusion criteria, the analytical sample contained 1,755 
adolescents who had both pre- and post- interview cortisol measurements as well as full 
data from CIDI interview by adolescent reports. Of these, 1,097 had additional 
information from PSAQ by parent reports.   
 
 
SALIVARY CORTISOL MEASURES – OUTCOME VARIABLES 
Cortisol levels in ng/mL were measured using saliva samples. Saliva samples 
were collected in a salivette by passive drool after the participant chewed on a piece of 








1.	  Extreme	  outlying	  cortisol	  measures	  	  (n=2)	  	  
2.	  Complete	  interview	  in	  more	  than	  1	  sitting	  	  (n=528)	  
3.	  Without	  valid	  start	  and	  end	  interview	  time	  (same	  n=528)	  
4.	  Interview’s	  end	  time	  before	  start	  time	  (n=9)	  	  	  	  	  	  
5.	  Interview	  start	  or	  end	  time	  too	  early	  (n=2)	  
6.	  c/p	  Asthma	  (potentially	  take	  steroid	  medications)	  	  (n=542)	  
7.	  c	  Diabetes	  	  (n=26)	  
8.	  c	  Current	  smoking	  	  (n=184)	  
9.	  c	  12-­‐month	  nicotine	  dependence	  (n=146)	  
10.	  c	  12-­‐month	  drug	  abuse/dependence	  	  (n=161)	  
11.	  c	  Current	  pregnant	  	  (n=10)	  
12.	  c	  Currently	  take	  contraceptive	  pills	  	  (n=114)	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sugarless gum immediately before and after the interview while the interviewer was 
present. The interviewer's laptop automatically recorded the time and date of each sample 
collection. The interviews were conducted throughout the day from 8:00 AM to 11:00 
PM.  The mean duration of the interview was 2.4 hours (SD =0.6).  Salivettes were 
treated with sodium azide at Harvard University to retard bacterial growth, centrifuged, 
and pre-labeled with participant identification numbers and study information prior to 
sample collection.  
After collection, samples were mailed to NIH where they were stored at -80 
Celsius until testing. Quantification of cortisol levels was done by a radioimmunoassay 
(SiemensDiagnostic). The sensitivity of the assay was 0.0165 ng/mL. Intra-and inter-
assay coefficients of variation were 5.4% and 26.0%, respectively. Similar coefficients of 
variation for this method have been reported previously [46]. 
We examined three outcome variables in the present study: 1) point-in-time 
cortisol at pre-interview, 2) point-in-time cortisol at post-interview, and 3) rate of change 
in cortisol (post-interview minus pre-interview cortisol divided by interview length in 
hours).  Since patterns revealed for post-interview cortisol were very similar to pre-
interview cortisol, their results were omitted in this report. 
 
DSM-IV DISORDER ASCERTAINMENT 
The current analyses are based on the adolescent interview to assess diagnostic 
criteria for mood and anxiety disorders. Mood disorders (major depressive disorder 
[MDD], dysthymic disorder, mania, and hypomania) and anxiety disorders (agoraphobia, 
generalized anxiety disorder, panic disorder, separation anxiety disorder, social phobia, 
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specific phobia, and posttraumatic stress disorder) were assessed in the CIDI. Definitions 
of all psychiatric disorders adhered to DSM-IV criteria. There was good concordance 
between psychiatric diagnosis from the modified CIDI and a clinical reappraisal sub-
sample [47]. 
 Impairment criteria from DSM-IV were based on an endorsement of some/a 
lot/extreme level of impairment or moderate/severe/very severe level of symptom 
severity. We used higher thresholds of impairment to define severity status in the study in 
order to identify disorders that were clinically significant.  The higher thresholds of 
impairment required endorsement of “a lot” or “extreme” impairment in daily activities, 
or “severe or very severe” distress. Mood and anxiety disorders required both distress and 
impairment to be reported by adolescents. The Interuniversity Consortium for Politician 
and Social Research (ICPSR) at the University of Michigan created an algorithm with 
SAS that output DSM diagnosis [48]. In addition, ICPSR performed a confidentiality 
review and consistency checks.   
 
OTHER COVARIATES 
The demographic covariates considered in the regression models included age, 
sex, race/ethnicity, and family income. We also examined health related covariates 
including sleep and suicidal behaviors. Quantile measurements were created for weekday 
sleep duration in hours, weekday bed time, and middle sleep time.  Middle sleep time 
served as an indicator of chronotype defined by dividing weekday sleep duration by two 
and adding it to weekday bedtime. The adolescents with the highest quantile group were 
used as reference. Suicidality was dichotomous and coded as present if lifetime suicide 
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ideation, plans or attempts were endorsed. These variables were chosen because they 
have been associated with psychiatric disorders and cortisol measurements in previous 
studies [49, 50]. 
 
STATISTICAL ANALYSIS 
Statistical analyses were completed using the SAS version 9.2 (The SAS Institute 
Inc. Cary, NC). The mean and standard deviation (SD) for salivary cortisol levels in 
ng/mL at pre-interview and rate of change are presented by time of day that salivary 
samples were collected. For descriptive purposes, traditional linear regression models 
(ordinary least square, OLS) were estimated in parallel with quantile regression (QR) 
analyses.      
The OLS models the relationship between one or more covariates X and 
conditional mean of the response variable Y given X=x, and hence are limited in that they 
do not extend to the non-central locations of a distribution.  QR is related to OLS but can 
model any point in the distribution of a continuous outcome variable, such as the 90th, 
75th, or 50th percentile (the best-known example of a percentile, being the 50th in a ranked 
distribution of numbers).   
“Quantile” is a general term for what may be referred to as percentiles, deciles, 
quartiles, etc., in specific cases. QR coefficients are interpreted in the same way as those 
from OLS, i.e. change in the response variable for each one-unit change in the covariates.  
QR would allow the impact of the independent variable to vary along the whole range of 
cortisol values.  Thus, estimating a family of conditional quantile functions can provide a 
more complete picture of covariate effects.  The main advantage of QR over OLS is its 
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flexibility for modeling data with heterogeneous conditional distributions and more 
robust against outliers in the response measurements.   
The equation for QR is given by yi=β0(p) + βi(p)xi +ε(p), where p is a given quantile: 
β0 is the constant at the pth quantile point (e.g. cortisol level for the ‘no disorder’ group at 
the pth quantile point in the study); βi  is the regression coefficient for a certain covariate  
x at the pth quantile point (e.g. estimated difference in the cortisol levels at the pth 
quantile point when comparing the ‘mania’ vs. ‘no mental disorder’); ε is the error term 
at the pth quantile point [51, 52]. 
In the current study, a typical OLS regression explaining cortisol level was first 
estimated to provide a basis for comparison with the QR.  Dummy variables were entered 
in the models for each level of the categorical independent variables. Adolescents who 
are male, non-Hispanic whites, highest family income group (PIR>6.0) with no disorder 
served as the reference groups. In the QR, 19 different conditional quantile functions 
were estimated, starting with the 0.05 (5%) and proceeding in 0.05 increments until the 
0.95 (95%) quantile (i.e. 0.05, 0.10, 0.15, …0.95).  The QR was estimated using PROC 
QUANTREG in SAS (SAS Institute, Cary, NC).  A Markov chain marginal bootstrap 
[53] was used to compute confidence intervals for every quantile estimates. 
We analyzed data in the following model sequences: First, QR models were 
employed to describe changes at each of the 19 cortisol quantiles over the time of day 
that the salivary cortisol sample were collected between 8:00 in the morning (earliest) 
and 11:00 in the evening (latest). This was done to determine the diurnal rhythm of 
cortisol levels to examine whether there was any variation in cortisol measurements over 
the time of day and examine whether the changes were equal across the range of 
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conditional distribution of cortisol measurements. Second, a set of demographic 
characteristics (sex, age, race, and family income) was entered into the QR model 
individually to describe changes at each of the 19 cortisol quantiles while holding the 
time of day constant.  Third, health related variables (weekday sleep duration, weekday 
bed time, weekday mid-sleep times, suicidality) and fourth, psychiatric disorder variables 
(mood and anxiety, and number of disorders) were entered into the QR model one at a 
time to determine if the changes at each of the 19 cortisol quantiles by disorder status 
were statistically significant independent of time of day and adolescent sex and age 
(linear and quadratic forms). Pre-interview cortisol level was also entered in the model 
when the model outcome was rate of change.    
Theoretically, estimates could be calculated at any point in the quantile 
distribution; the selection of these 19 quantile points was arbitrary with intention to 
provide a full range view of the variation. In result tables we presented estimates at 10, 
25, 50, 75, 90th percentiles only due to space consideration.  
The QR plots were used to help to reveal whether effects of independent variables 
were constant across the conditional quantile distribution of the outcome variable. For 
example, variation in pre-interview cortisol across the presence or absence of a disorder 
may be larger among individuals with high cortisol levels, as compared to those with 
low-to-medium pre-interview cortisol in the distribution.  In another circumstance, an 
association linking disorder status with pre-interview cortisol may only be present among 
individuals at the higher pre-interview cortisol levels.   
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RESULTS:	  
DEMOGRAPHIC BREAKDOWN OF THE SAMPLE 
In this analytical sample, about half of the sample was male (51.6%) and the mean 
age was 15.0 years (SD=1.4). Non-Hispanic Whites comprised 56.0% of the sample, non-
Hispanic blacks 18.9%, Hispanic 19.3%, and other race adolescents 5.8%.    
 
CORTISOL LEVELS BY TIME OF DAY  
OLS displayed that both pre- and post-interview cortisol levels were higher in the 
earlier time categories than later ones (Table 1, Figure 1).  As the post-interview cortisol 
samples were collected 2.4 hours (SD=0.6) later on average after the pre-interview 
sample collection, the post-interview cortisol levels was consistently lower at each time 
of day category.  The magnitude of the rate of change was greater in the earlier time 
categories and diminished over the time of day. 
The QR models revealed that both pre-interview and rate of cortisol change were 
decreased in the later time of day categories than those in the earlier time of day 
categories.  Figure 2 is a QR process graph. In Figure 2a the y-axis depicts the value of 
quantile regression coefficient; the x-axis values are quantile points.  The comparison 
group is the earliest time of day (8am-11am), for which the regression coefficient is zero 
across all x-axis values. If and when respondents in later time of day categories have 
cortisol levels that are not appreciably different from the cortisol level of the earliest time 
of day category (i.e. reference group), the resulting plot is flat at quantile regression 
coefficient at zero for all values along the x-axis. The blue highlights the 95% confidence 
interval thus any point falling above or below the blue highlighting is significant. If the 
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significant value falls below the absolute zero mark, then the result is a negative 
association. The opposite is true for significant values that are above the absolute zero 
mark. The nomenclature for the y-axis is as follows: intercept 8am-<11am serving as 
reference, zero line, startT4catR1 represents 11am-<2pm, startT4catR2 represents 2pm-
<5pm, and startT4catR3 represents >=5pm. 
The patterns of associations varied across categories of time of day for pre- 
interview cortisol levels, i.e. cortisol levels in all three later time of day categories were 
greater compared to the earliest time of day (Figure 2a). The cortisol levels associated 
with the latest time of day categories were more pronounced in their departure from zero 
(i.e. times >5pm). This change was greater in the pre-interview cortisol level than the 
post-interview cortisol. The effect was downwardly associated with respondent’s cortisol 
level over the full range of quantile distributions of cortisol with a stronger effect among 
those respondents with higher cortisol values (higher tail in quantile plot, quantile 
points>50 percentile).  However, there was no difference between the rates of cortisol 
change between the two earlier times of day categories (Figure 2b). The earlier time 
categories were associated with a greater negative rate of change than the later time of 
day categories. There was no significant variation across quantile distributions except for 
the end tail of the quantiles likely due to small n.    
Note that patterns of post-interview cortisol are similar to those of pre-interview 
cortisol but to a lesser extent.  The result tables/figures will be presented thereafter for 
pre-interview cortisol and rate of change only. The results for post-interview cortisol 
were omitted in the report (available upon request). 
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CORTISOL LEVELS BY DEMOGRAPHIC CHARACTERISTICS 
 Table 2 presents the OLS and quantile coefficient estimates for selected quantiles 
of pre-interview cortisol (Table 2a) and rate of change cortisol measurements (Table 2b) 
by demographic characteristics (sex, age, race/ethnicity, family income). Based on the 
OLS regression models, the younger age groups (13-14y, 15-16y) and ‘other’ race group 
had significantly lower pre-cortisol level and greater rates of change than oldest age 
group (17-18y) or non-Hispanic white, respectively.    
The QR showed a more detailed view across the quantile distributions for the 
outcome variables than that in OLS results. The QR revealed there was no significant sex 
differences in terms of pre-interview, however, rate of change was significantly smaller at 
the lower end of quantile distribution among females that that in males. The younger age 
groups (13-14y, 15-16y) were more likely to have significantly lower pre-interview 
cortisol level across all quantiles than the oldest age group (17-18y) with the exception of 
the 0.25 quantile point where significance was not reached. The difference was 
significantly widened especially for 13-14y adolescents in the range of higher than 
average cortisol level (i.e. quantile>50 percentile) in quantile distributions.  There was no 
age difference for rate of change.  
The ‘Other’ race group was likely to have lower pre-interview cortisol than white 
at upper tail of the quantile distribution (50-90 percentiles), while the post-interview 
cortisol level was higher in Hispanic group than White around the upper-middle quantiles 
(60-85 percentiles). Both Hispanic and black groups showed greater rates of change than 
that in white especially at the lower tail quantile distribution (<50 percentile).  
Compared to adolescents with high family income (PIR>6), those from lower 
income (PIR<1.5 and PIR <3) families showed greater rates of change that were limited 
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to the lower tail of quantile distribution.  Only at isolated quantiles (at 50 and 75 
percentiles), was the pre-interview cortisol level higher in PIR <3.0 group than PIR >6.0 
group.   
 
CORTISOL LEVELS BY HEALTH RELATED VARIABLES 
Table 3 reports OLS and QR coefficients for pre-interview (Table 3a) and rate of 
change in cortisol (Table 3b) for sleep and suicidality variables. The OLS showed that 
earlier weekday bed time (<=22:00) or earlier weekday mid-sleep time (<=27) were 
significantly associated with lower pre-interview cortisol level than those with bed time 
after 11pm (>23:00), or delayed mid-sleep times (>27). However, bedtime and mid-sleep 
times were not associated with rates of change. The OLS displayed no significant change 
in pre-interview and rate of change in cortisol for sleep duration and suicidality.  
The QR results showed that adolescents with shorter weekday sleep duration (the 
1st, 2nd, or 3rd quantiles, i.e.<=8.5hrs) had significant higher pre-interview cortisol level 
only at the mid-quantile distributions (40-50 percentiles) and higher rate of change at the 
upper middle quantile distribution (50-75 percentiles) than those with more than 8.5 
hours sleep duration (the 4th quantile).  The earliest bed time group (<=22:00) and mid-
sleep times (the 1st, 2nd, 3rd quantiles, i.e. <=27) were significantly associated with lower 
pre-interview cortisol levels than those with later bed time (4th quantile, i.e. >23:00) or 
delayed mid-sleep times (4th quantile, i.e. >27).  
Dose-response effects were evident for mid-sleep times; specifically, the earlier 
the mid-sleep times, the lower the level of pre-interview cortisol.  Earlier bedtime 
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(<=22:00) and earlier mid-sleep times (<=22) were significantly associated with lower 
rate of change in cortisol with little variation across the quantile distribution. 
 Adolescents who reported suicidal thoughts/plan/attempts had significantly higher 
rates of change than those without suicidality across the entire quantile distribution 
except that it was not significant at the upper tail of the distribution likely due to a few 
outliers. There was no significant difference in pre-interview cortisol level by suicidality.   
 
CORTISOL LEVELS BY DISORDER STATUS 
Table 4 displays OLS and QR pre-interview (Table 4a) and rate of change (Table 
4b) by disorder status. The OLS analysis did not detect the associations between different 
status (12-month severe, 12-month, and lifetime) of mood disorder and anxiety disorder 
and outcome variables (pre-interview cortisol and rate of change) with the exception that 
levels of pre-interview cortisol were lower among adolescents with lifetime mood 
disorder compared to those without DSM-IV disorders (i.e. without mood, anxiety, 
ADHD, and behavior disorders). Comparatively, lifetime mood disorders were associated 
with a higher pre-interview cortisol than those with no DSM-IV disorder (p<0.05). 
Neither disorder status for anxiety nor mood displayed any significant association with 
cortisol rate of change. Pre-interview or rate of cortisol change was not associated with 
number of classes of disorders.  
Per QR there is no association between 12-month severe or non-severe mood 
disorder and pre-interview cortisol level.  However, adolescents with lifetime mood 
disorder had lower pre-interview cortisol level than those without a DSM-IV disorder, 
especially at lower tail of quantile distributions. With respect to rate of cortisol change, 
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greater rate of change was observed for adolescents with 12-month severe mood disorder 
at isolated quantile point (25 percentile) compared to those without DSM-IV disorders. 
Adolescents with 12-month mood disorder had greater rate of change at a wide range 
covering entire lower tail of quantile distribution (<75 percentiles). Lifetime mood 
disorder was not associated with rate of cortisol change.  
Regarding anxiety disorders, pre-interview cortisol level was not associated with 
anxiety disorder status except that adolescents with 12-month (severe and non-severe) 
anxiety disorder showed an elevated pre-interview cortisol level that were marginally 
significant (p<0.10) compared to those without DSM-IV disorders.   Adolescents with 
anxiety disorder (12-month severe, 12-month, or lifetime) had greater rate of change than 
those without disorder at the quantile distributions on the lower and middle tail (quantiles 
<75 percentiles) of quantile distribution.  
There were no significant changes in post-interview cortisol by mood or anxiety 
disorder status nor number of classes of disorder. Pre-interview cortisol was not 
associated with number of classes of disorders but adolescents with any lifetime 
diagnosis, one class 12 month diagnosis, two classes 12 month diagnosis, and three or 
more classes 12 month diagnosis was associated with a increase in cortisol rate of change 




In a large, U.S. population-based sample we found that stress reactivity, in 
response to an acute minor stressor, was altered with greater magnitude of change in 
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cortisol before and after the interview in adolescents with mood and anxiety disorders 
compared to healthy control adolescents. These findings provide biologic evidence for 
greater stress reactivity in adolescents with anxiety and depression in non-clinical 
samples.  
Studies that have used moderate to intense stressors, such as the Trier Social 
Stress Test, have not found an association between depression and cortisol reactivity [54]. 
When one considers our findings in the context of these studies, it is possible that 
depressed adolescents are more sensitive to the daily mild stressors, such as our 
interview, than their non-depressed counterparts but not to more intense stressors.  
We also found that that cortisol reactivity was influenced by disorder severity and 
chronicity. Rate of cortisol change was affected by 12-month mood disorder but not 
lifetime.  However, anxiety disorder regardless of severity or chronicity was associated 
with greater rate of cortisol change. Severe 12-month mood and anxiety disorders were 
more significantly associated with rate of cortisol change than their non-severe 
counterparts. In addition, stress reactivity was altered by the number of disease classes an 
adolescent had. This provides further biological evidence that stress reactivity plays an 
important role in the relapses and worsening of depression and anxiety. Our findings are 
in contrast to those of Harkness et al who found that individuals with mild/moderate 
depression had increased reactivity but those with moderate/severe had blunted cortisol 
response [55]. Their study, however, focused on the influence of childhood maltreatment, 
a factor we did not consider, on cortisol response. 
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While it is known that there is an association between cortisol reactivity and 
subsequent suicide attempts, very little research has studied cortisol reactivity and 
past/current suicidal ideation. Beauchaine et al used the dexamethasone suppression test 
and found that adolescent girls with heightened reactivity to the test had increased 
suicidal ideation [56].  
On the other hand, cortisol non-suppressors (those individuals that reacted less to 
the test) with the dexamethasone test had increased rates of suicides [57]. We report the 
first study to examine the link between adolescent cortisol reactivity in response to a mild 
social stressor and suicidal ideation. Similar to our findings with anxiety and mood 
disorders, those adolescents with increased cortisol reactivity were more likely to have 
suicidal behavior (ideation/plans/attempts) indicating an underlying reactivity factor in 
the pathophysiology.  
 We also studied the relationship between adolescent cortisol and the circadian 
clock, sex, age, family income, and sleep. It is known that cortisol displays a strong 
diurnal rhythm with the highest cortisol levels, known as the cortisol awakening 
response, occurring within an hour of awaking. Cortisol levels then decline throughout 
the day and reach a nadir around midnight [58]. The decrease throughout the day is called 
the diurnal cortisol slope. Our finding of elevated cortisol in the morning and decreases 
throughout the day is consistent with the literature [58].  Furthermore, our data support 
the prevailing findings in the literature that the diurnal cortisol slope decreases as the day 
progresses (i.e. the rate of change of cortisol decreases as the day progresses) [59]. 
 While it is known that women display a greater rate of many anxiety and mood 
disorders [60], the majority of literature demonstrates that males have a greater cortisol 
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change in response to a stressor and are, therefore, more stress reactive, than females [61, 
62]. However, we found no association between gender and pre-interview or rate of 
cortisol change in response to an acute mild stressor. This is possibly due to the nature of 
the stressor that we used, as Stroud et al found that the HPA axis of men vs. females are 
activated by different types of stressors. Specifically, men had greater cortisol reactivity 
to achievement-based tasks while women had greater reactivity to interpersonal tasks 
[63].  Our stressor was neither achievement-based nor involved significant interpersonal 
challenges.  
To better understand and gain a more complete developmentally oriented cortisol 
picture it is important to consider age differences along with sex differences. Studies 
examining an association between age and cortisol reactivity have been mixed [64, 65]. 
The prevailing theory, however, is that cortisol reactivity increases in the transition from 
childhood to adolescents [66] in accordance with sexual maturation [67]. As our study 
sample only included adolescents aged 13-18y, the fact that we did not see an association 
between cortisol reactivity and age is possibly because the majority of our participants 
were in the latter stages of pubertal development and had already undergone changes in 
reactivity.  
Using the study sample from this report, we have previously shown that 
adolescents in disadvantaged neighborhoods had higher pre-interview cortisol and steeper 
rates of change in cortisol over the interview [68]. Neighborhood socioeconomic status 
was comprised of six U.S. Census Short Form 3 indicators: log median household 
income, % households with interest, dividend, or rental income, log median value of 
housing units, % persons over age 25 with high school degree, % persons over 25 with 
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college degree, and % persons in executive, managerial, or professional specialty 
operations [69]. The association between neighborhood status and pre-interview cortisol 
level, as well as cortisol rate of change, remained significant in the unadjusted models as 
well as those adjusted for household income.  
With the present results, family income is associated with higher pre-interview 
cortisol and a greater rate of change at various quantile points. As with living in a 
disadvantaged neighborhood, these results perhaps reflect heightened reactivity to and 
recovery from the stimuli of the interview. As stated in the methods section, our pre- 
post- and rate of cortisol change cannot be precisely correlated with a specific period in 
HPA activation. We hypothesize, therefore, that these results are indicative of an 
increased reactivity to and recovery from the stress of the interview in adolescents from 
low-income families.  
The suprachiasmatic nucleus of the hypothalamus is important in the regulation of 
cortisol’s circadian rhythm. Many adolescents, however, are subject to increasingly 
demanding academic and extracurricular requirements that impinge on healthy sleep 
schedules. The prevalence of childhood sleep problems is estimated to range from 20-
30% and nearly half of these problems persist into adulthood [70].  Very little research, 
however, has been done on the connection between HPA functioning and sleep within the 
adolescent population. HPA axis alterations, however, could serve as the mechanism 
through which poor sleep influences physical and mental health. The majority of 
literature on this subject, however, has focused on the physiologic cortisol awakening 
response and not on cortisol reactivity.  
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Pesonen et al performed the only study on the associations between cortisol as 
influenced by the dexamethasone suppression test and sleep in adolescents [58]. They 
reported that adolescent boys had a decreased cortisol awakening response in associated 
with short sleep duration and lower sleep quality although the latter result was just below 
significance. No associations were found with girls.  
Other than our study, only two other studies have examined the relationship 
between adolescent cortisol reactivity and sleep in response to a psychological stimulus 
and they were each limited by small sample sizes. Raikkonen et al used the Trier Social 
Stress Test on a sample of 282 8-year-old children undergoing sleep monitoring via 
actigraphy [71]. They concluded that children with low compared to average-high sleep 
efficiency had higher peak cortisol and greater rates of change in response to a social 
stressor.  
Although our study design did not permit the evaluation of sleep efficiency, our 
findings of increased cortisol reactivity to the interview in adolescents with earlier 
bedtimes and earlier mid-sleep times also suggest that sleep may serve as an important 
mediator between stress reactivity and the HPA axis. Capaldi et al studied 31 adolescents 
aged 10-17 and found that greater sleep-wake behavior problems were associated with a 
decreased cortisol reactivity in response to a performance stressor [72]. Unlike 
Raikkonen, they did not find an association between sleep quality and cortisol reactivity. 
Our data add important information to the very scarce literature on HPA involvement and 
adolescent sleep.  
 
STRENGTHS AND LIMITATIONS 
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Previous research has been hampered by small sample sizes as well as the 
invasiveness of obtaining serum to study adolescent cortisol. By using salivary cortisol, a 
lab value that has been shown to correlate well with serum cortisol [17], we circumvented 
this previous limitation. An additional benefit of using saliva is that it allowed us to 
obtain a large number of subjects.  
Using quantile regression we were able to acknowledge and address the inter-
individual heterogeneity of cortisol. Many previous studies have likely not found 
significance as they made the assumption that all cortisol quantiles react in a similar way 
(i.e. somebody with a baseline low cortisol will display similar reactivity to somebody 
with a basal cortisol level in the medium range).  
There were several components of the study specifically designed to assess 
fieldwork quality. The computerized CIDI had a built-in clock that recorded speed of data 
entry ensuring the interviewers did not skip or rush through sections. In addition, 
supervisors contacted 10% of households to review addresses, enumeration, random 
selection procedures, length of interviews, and responses to random questions [73]. 
Our results are subject to several limitations. We only collected cortisol pre- and 
post-interview and did not collect it across the day. In addition, we did not collect cortisol 
at awakening nor standardize the times of sampling as this was not possible in this large 
epidemiologic study. There was also a range in the duration of the interview. The 
variation in interview length was intrinsic to the survey design as each disorder had a 
stem-branch structure [73]. Despite the two-day General Interview Training course and 
five-day NCS-A that all interviewers completed, adolescents may still feel more 
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comfortable talking to certain interviewers and that different interviewers have different 
tones and delivery.   
Cortisol is an extremely variable hormone and its values can vary significantly 
from minute to minute. As we did not use a laboratory procedure specifically designed to 
induce anxiety, such as the Trier Social Stress test, our results cannot be neatly correlated 
to specific phases in the HPA axis activation such as the anticipatory, stress, and recovery 
stages. We deemed such a test inappropriate with our sample population. Instead, our 
study reflects different naturalistic settings.  
The participant is disrupted from their standard schedule/routine to participate in 
the interview. Their level of activity prior to sitting down for the interview is not 
recorded. While the interview is not designed to elicit stress, we hypothesize that the 
interaction with a stranger and personal nature of the mental health questions will invoke 
stress in the majority of the adolescents. As the participants remain seated throughout the 
interview, it is known that the post-interview sample is one collected after the subject has 
been seated for an average of 2.4 hours. It is not possible to determine to what extent the 
changes in cortisol are from circadian nature of cortisol, or the low-activity level of the 
seated interview.  
 
In conclusion, in a U.S. based population study of adolescents we found 
biological evidence for greater stress reactivity in adolescents with mood and/or anxiety 
disorders compared to their non-anxious or depressed counterparts. Furthermore, this 
relationship is influenced by other health related factors such as sleep. These findings 
suggest that cortisol reactivity might comprise a biological index of major depression and 
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anxiety in adolescents and may add a component to the diagnosis and monitoring of 
adolescent mood and anxiety disorders. Furthermore, the biological data has the potential 
to aid in the identification of distinct syndromes within each of the mood or anxiety 
disorders. Lastly, these findings may also provide important information on the 
mechanisms of adolescent mood and anxiety disorders, particularly the role of the HPA 
axis in stress reactivity that may underlie these disorders.  
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TABLES	  
TABLE 1. MEAN CORTISOL MEASURES (NG/ML) FOR TOTAL AND BY TIME OF DAY CORTISOL SAMPLE COLLECTED 
	  	   Time	  of	  day	  Cortisol	  Sample	  Collected	   N	   Mean	   SD	  
Regression	  Coefficient	   T-­‐test	  of	  post-­‐	  &	  pre-­‐	  cortisol	  change	  
β	   95%	  CI	   t-­‐stat	   p-­‐value	  
Pre-­‐interview	  
	  	  
1755	   0.262	   0.229	  
	  	  
	  	   	  	  
Post-­‐interview	   1755	   0.149	   0.152	   	  	   	  	  
Change	  	   1755	   -­‐0.114	   0.234	   -­‐20.34	   <.0001	  
Rate	  of	  change	   1755	   -­‐0.049	   0.110	   	  	   	  	  
Pre-­‐Interview	  
1:	  <11am	   313	   0.396	   0.295	   Reference	   	  	   	  	   	  	  
2:	  11am-­‐<2pm	   333	   0.285	   0.225	   -­‐0.1112****	   -­‐0.1448,0.4201	   	  	   	  	  
3:	  2pm-­‐<5pm	   597	   0.239	   0.212	   -­‐0.1572****	   -­‐0.1870,	  -­‐0.1274	   	  	   	  	  
4:	  5pm-­‐<8pm	   491	   0.196	   0.155	  
-­‐0.2034****	   -­‐0.2340,-­‐0.1727	  	  
	  	   	  	  
5:	  >=8pm	   21	   0.114	   0.109	   	  	   	  	  
Post-­‐Interview	  
1:	  <11am	   17	   0.258	   0.195	  
Reference	   	  	  
	  	   	  	  
2:	  11am-­‐<2pm	   352	   0.190	   0.183	   	  	   	  	  
3:	  2pm-­‐<5pm	   383	   0.167	   0.151	   -­‐0.0265*	   -­‐0.0478,	  -­‐0.0052	   	  	   	  	  
4:	  5pm-­‐<8pm	   602	   0.134	   0.135	   -­‐0.0595***	   -­‐0.0789,	  -­‐0.0402	   	  	   	  	  
	   45	  
5:	  >=8pm	   401	   0.113	   0.129	   -­‐0.0807***	   -­‐0.1018,	  -­‐0.0596	   	  	   	  	  
Change	  	  	  
1:	  <11am	   313	   -­‐0.199	   0.329	   Reference	   	  	   -­‐10.7	   <.0001	  
2:	  11am-­‐<2pm	   333	   -­‐0.111	   0.249	   -­‐0.004	   -­‐0.0266,	  0.0184	   -­‐8.19	   <.0001	  
3:	  2pm-­‐<5pm	   597	   -­‐0.100	   0.205	   -­‐0.0303**	   -­‐0.0506,	  -­‐0.0100	   -­‐11.86	   <.0001	  
4:	  5pm-­‐<8pm	   491	   -­‐0.080	   0.164	  
-­‐0.0475***	   -­‐0.0687,	  -­‐0.0263	  
-­‐10.8	   <.0001	  
5:	  >=8pm	   21	   -­‐0.047	   0.109	   -­‐1.99	   0.0601	  
Rate	  of	  change	  	  	  
1:	  <11am	   313	   -­‐0.081	   0.149	   Reference	   	  	   	  	   	  	  
2:	  11am-­‐<2pm	   333	   -­‐0.048	   0.125	   -­‐0.0064	  	  	   -­‐0.0184,	  0.0056	   	  	   	  	  
3:	  2pm-­‐<5pm	   597	   -­‐0.043	   0.092	   -­‐0.0171*	   -­‐0.0280,	  -­‐0.0063	   	  	   	  	  
4:	  5pm-­‐<8pm	   491	   -­‐0.037	   0.085	  
-­‐0.0266***	   -­‐0.0379,	  -­‐0.0153	  
	  	   	  	  
5:	  >=8pm	   21	   -­‐0.012	   0.054	   	  	   	  	  
NOTE: use pre-interview time for pre-Interview cortisol, change, rate of change; use post-interview time for post-interview cortisol sample; Change = post- minus pre- interview cortisol measures; Rate 
of change = post- minus pre-interview cortisol measures divided by interview length in hours; β = Linear regression unadjusted for pre-interview and post-interview cortisol measures, adjusted pre-
interview cortisol level for change and rate of change in cortisol measures. *p<.05, **p<.01, ***p<.001, ****p<.0001 
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TABLE 2A.  QUANTILE COEFFICIENT ESTIMATES (95% CI) FOR SELECTED QUANTILES, PRE-INTERVIEW CORTISOL 
MEASUREMENTS BY DEMOGRAPHICS  
	  	   	  	   OLS	   Quantile	  Coefficient	  (95%	  CI)	  
	  	   	  	   β	   95%	  CI	   0.1	   95%	  CI	   0.25	   95%	  CI	   0.5	   95%	  CI	   0.75	   95%	  CI	   0.9	   95%	  CI	  
Pre-­‐interview	  
Cortisol	  level	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
	  	  
<11am	  
(Reference)	   Reference	   	  	   Reference	   	  	   Reference	   	  	   Reference	   	  	   Reference	   	  	   Reference	   	  	  
	  	  
11am-­‐
<2pm	   -­‐0.1112****	  
-­‐
0.1448,
0.4201	   -­‐0.0037	  
-­‐0.0225,	  
0.0152	   -­‐0.059****	  
-­‐0.0827,	  -­‐







0.1297	   -­‐0.194****	  
-­‐0.2933,	  -­‐
0.0947	  








0.0170	   -­‐0.086****	  
-­‐0.1096,	  -­‐







0.1783	   -­‐0.301****	  
-­‐0.3860,	  -­‐
0.2160	  








0.0372	   -­‐0.113****	  
-­‐0.1359,	  -­‐







0.2289	   -­‐0.345****	  
-­‐0.4245,	  -­‐
0.2655	  
Demographics	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
Sex	   0.	  Female	   0.0115	  
-­‐0.009,	  
0.032	   0.0032	  
-­‐0.0064,	  
0.0129	   0.009a	  
-­‐0.0012,	  
0.0192	   0.0105	  
-­‐0.0044,	  
0.0255	   0.0026	  
-­‐0.0309,	  
0.0362	   -­‐0.0130	  
-­‐0.0645,	  
0.0385	  
	  	   1.	  Male	  	   Reference	   	  	   Reference	   	  	   Reference	   	  	   Reference	   	  	   Reference	   	  	   Reference	   	  	  
Age	  group	   1:	  13-­‐14y	   -­‐0.05517***	  
-­‐0.084,	  
-­‐0.026	   -­‐0.018**	  
-­‐0.0289,	  -­‐
0.0071	   -­‐0.0140	  
-­‐0.0311,	  
0.0031	   -­‐0.034**	  
-­‐0.0558,	  -­‐
0.0122	   -­‐0.064**	  
-­‐0.1053,	  -­‐
0.0227	   -­‐0.1061*	  
-­‐0.1903,	  -­‐
0.0219	  
	  	   2:	  15-­‐16y	   -­‐0.03015*	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-­‐0.001	   0.021***	   0.0097	   0.0111	   0.0024	   0.0147	   0.0253	  
	  	   3.	  17-­‐18y	   Reference	   	  	   Reference	   	  	   Reference	   	  	   Reference	   	  	   Reference	   	  	   Reference	   	  	  
Race/Ethnicity	   1.	  Hispanic	   0.0132	  
-­‐0.014,	  
0.040	   -­‐0.0080	  
-­‐0.0202,	  
0.0042	   0.0020	  
-­‐0.0166,	  
0.0206	   0.0080	  
-­‐0.0137,	  
0.0297	   0.0290	  
-­‐0.0196,	  






black	   -­‐0.0173	  
-­‐0.044,	  
0.010	   -­‐0.01*	  
-­‐0.0193,	  -­‐
0.0007	   -­‐0.0070	  
-­‐0.0220,	  
0.0080	   -­‐0.0069	  
-­‐0.0287,	  
0.0149	   -­‐0.0260	  
-­‐0.0648,	  
0.0128	   -­‐0.0380	  
-­‐0.1088,	  
0.0328	  	  
	  	   3.	  Other	   -­‐0.05317*	  
-­‐0.098,	  
-­‐0.009	   -­‐0.0020	  
-­‐0.0229,	  
0.0189	   -­‐0.0160	  
-­‐0.0366,	  
0.0046	   -­‐0.0407**	  
-­‐0.0691,	  -­‐
0.0122	   -­‐0.0700**	  
-­‐0.1186,	  -­‐






white	   Reference	   	  	   Reference	   	  	   Reference	   	  	   Reference	   	  	   Reference	   	  	   Reference	   	  	  
Family	  Income	  
1.	  PIR	  
<=1.5	   0.0079	  
-­‐0.023,	  
0.039	   -­‐0.0074	  
-­‐0.0221,	  
0.0073	   -­‐0.0060	  
-­‐0.0225,	  
0.0105	   0.0005	  
-­‐0.0203,	  
0.0213	   0.0197	  
-­‐0.0311,	  





<=3.0	   0.02509	  a	  
-­‐0.004,	  
0.054	   0.0016	  
-­‐0.0117,	  
0.0149	   0.0091	  
-­‐0.0098,	  
0.0281	   0.0197*	  
0.0009,	  
0.0386	   0.0507*	  
0.0083,	  





<=6.0	   -­‐0.0045	  
-­‐0.030,	  
0.022	   0.0016	  
-­‐0.0098,	  
0.0130	   -­‐0.0020	  
-­‐0.0144,	  
0.0104	   -­‐0.0049	  
-­‐0.0235,	  
0.0138	  	   0.0067	  
-­‐0.0289,	  
0.0422	   0.0008	  
-­‐0.0625,	  
0.0640	  
	  	   4.	  PIR	  >6.0	   Reference	   	  	   Reference	   	  	   Reference	   	  	   Reference	   	  	   Reference	   	  	   Reference	   	  	  
NOTE:	  OLS	  and	  QR	  models	  for	  demographics	  adjusted	  for	  time	  of	  day	  pre-­‐interview	  sample	  collected	  only	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TABLE 2B.  QUANTILE COEFFICIENT ESTIMATES (95% CI) FOR SELECTED QUANTILES, RATE OF CHANGE IN CORTISOL 
MEASUREMENTS BY DEMOGRAPHICS  
	  	   	  	   OLS	   Quantile	  Coefficient	  (95%	  CI)	  
	  	   	  	   β	   95%	  CI	   0.1	   95%	  CI	   0.25	   95%	  CI	   0.5	   95%	  CI	   0.75	   95%	  CI	   0.9	   95%	  CI	  
Rate	  of	  change	  in	  
cortisol	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
	  	  
8am-­‐11am	  
(Reference)	   Reference	   	  	   Reference	   	  	   Reference	   	  	   Reference	   	  	   Reference	   	  	   Reference	   	  	  
	  	   11am-­‐<2pm	   -­‐0.0064	  	  	  
-­‐0.0184,	  
0.0056	   0.0020	  
-­‐0.0056,	  
0.0096	   0.0012	  
-­‐0.0072,	  
0.0095	   0.0010	  
-­‐0.0096,	  
0.0115	   0.0028	  
-­‐0.0064,	  
0.0119	   -­‐0.0078	  
-­‐0.0318,	  
0.0161	  
	  	   2pm-­‐<5pm	   -­‐0.0171*	  
-­‐0.0280,	  -­‐
0.0063	   -­‐0.0054	  
-­‐0.0134,	  












0.0047	   -­‐0.0161	  
-­‐0.0362,	  
0.0039	  






















0.0166	   -­‐0.0384***	  
-­‐0.0594,	  -­‐
0.0174	  
Demographics	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  







0.0012	   -­‐0.0029	  
-­‐0.0067,	  
0.0008	   -­‐0.0021	  
-­‐0.0064,	  
0.0022	   -­‐0.0041	  
-­‐0.0092,	  
0.0010	   -­‐0.0038	  
-­‐0.0147,	  
0.0072	  
	  	   0.	  Male	  	   Reference	   	  	   Reference	   	  	   Reference	   	  	   Reference	   	  	   Reference	   	  	   Reference	   	  	  




0.038	   0.0001	  
-­‐0.0065,	  
0.0067	   -­‐0.0013	  
-­‐0.0064,	  
0.0039	   -­‐0.0037	  
-­‐0.0095,	  
0.0020	   -­‐0.0060	  
-­‐0.0133,	  
0.0013	   -­‐0.0097	  
-­‐0.0244,	  
0.0049	  
	  	   2:	  15-­‐16y	   0.01378	  a	  
-­‐0.001,	  
0.028	   -­‐0.0043	  
-­‐0.0121,	  
0.0034	   -­‐0.0029	  
-­‐0.0082,	  
0.0024	   -­‐0.0047	  
-­‐0.0105,	  
0.0011	   -­‐0.0026	  
-­‐0.0099,	  
0.0048	   -­‐0.0017	  
-­‐0.0186,	  
0.0152	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   3.	  17-­‐18y	   Reference	   	  	   Reference	   	  	   Reference	   	  	   Reference	   	  	   Reference	   	  	   Reference	   	  	  
Race/Ethnicity	   1.	  Hispanic	   -­‐0.0026	  
-­‐0.016,	  






0.0115	   0.0063*	  
0.0003,	  
0.0123	   0.0048	  
-­‐0.0015	  ,	  






black	   0.0061	  
-­‐0.008,	  










0.0122	   0.0008	  
-­‐0.0052,	  
0.0067	   -­‐0.0102	  
-­‐0.0222,	  
0.0017	  




0.054	   0.0091	  
-­‐0.0018,	  
0.0199	   0.0055	  
-­‐0.0014,	  
0.0124	   0.0079a	  
-­‐0.0012,	  
0.0171	   0.0074	  
-­‐0.0082,	  






white	   Reference	   	  	   Reference	   	  	   Reference	   	  	   Reference	   	  	   Reference	   	  	   Reference	   	  	  
Family	  Income	   1.	  PIR	  <=1.5	   0.0047	  
-­‐0.011,	  
0.020	   0.0078*	  
0.0009,	  
0.0148	   0.0059**	  
0.0014,	  






0.0102	   0.0002	  
-­‐0.0158,	  
0.0163	  
	  	   2.	  PIR	  <=3.0	   0.0003	  
-­‐0.014,	  
0.015	   0.0095***	  
0.0039,	  
0.0151	   0.0036	  
-­‐0.0016,	  
0.0087	   0.0035	  
-­‐0.0023,	  
0.0092	   -­‐0.0001	  
-­‐0.0074,	  
0.0073	   -­‐0.0021	  
-­‐0.0222,	  
0.0181	  
	  	   3.	  PIR	  <=6.0	   0.0046	  
-­‐0.008,	  
0.018	   0.0022	  
-­‐0.0043,	  
0.0087	   -­‐0.0006	  
-­‐0.0052,	  
0.0040	   -­‐0.0018	  
-­‐0.0076,	  
0.0040	   0.0003	  
-­‐0.0067,	  
0.0072	   -­‐0.0019	  
-­‐0.0165,	  
0.0127	  
	  	   4.	  PIR	  >6.0	   Reference	   	  	   Reference	   	  	   Reference	   	  	   Reference	   	  	   Reference	   	  	   Reference	   	  	  
NOTE:	  OLS	  and	  QR	  models	  adjusted	  for	  pre-­‐interview	  cortisol	  level,	  for	  demographics	  additionally	  adjusted	  for	  time	  of	  day	  pre-­‐interview	  sample	  collected	  
a	  p<0.10;	  *	  p<.05;	  **	  p<.01;	  ***	  p<.001;	  ****	  p<.0001	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TABLE 3A.  QUANTILE COEFFICIENT ESTIMATES (95% CI) FOR SELECTED QUANTILES, PRE-INTERVIEW CORTISOL 
MEASUREMENTS BY HEALTH RELATED VARIABLES 
	  	   	  	   OLS	   Quantile	  Coefficient	  (95%	  CI)	  
	  	   	  	   β	   95%	  CI	   0.1	   95%	  CI	   0.25	   95%	  CI	   0.5	   95%	  CI	   0.75	   95%	  CI	   0.9	   95%	  CI	  
Suicidality	   1:	  Yes	   -­‐0.00218	  
-­‐0.040,	  
0.036	   -­‐0.0043	  
-­‐0.0189,	  
0.0102	   -­‐0.0089	  
-­‐0.0294,	  
0.0116	   -­‐0.0102	  
-­‐0.0425,	  
0.0222	   0.0466	  
-­‐0.0155,	  
0.1087	   0.0259	  
-­‐0.0703,	  
0.1221	  





<=7hrs	   0.0118	  
-­‐0.017,	  
0.041	   0.007	  
-­‐0.0054,	  
0.0194	   0.005	  
-­‐0.0113,	  
0.0213	   0.0023	  
-­‐0.0203,	  
0.0249	   0.0197	  
-­‐0.0240,	  






<=8hrs	   0.00239	  
-­‐0.025,	  
0.030	   0.003	  
-­‐0.0080,	  
0.0140	   0.0052	  
-­‐0.0080,	  
0.0185	   -­‐0.0054	  
-­‐0.0263,	  
0.0156	   0.0028	  
-­‐0.0339,	  






<=8.5hrs	   0.02833	  
-­‐0.018,	  
0.075	   0.0052	  
-­‐0.0245,	  
0.0350	   0.0225	  
-­‐0.0117,	  
0.0567	  	   0.0384*	  
0.0030,	  
0.0738	   0.0408	  
-­‐0.0289,	  






8.5hrs	   Reference	   	  	   Reference	   	  	   Reference	   	  	   Reference	   	  	   Reference	   	  	   Reference	   	  	  







0.018	   -­‐0.0033	  
-­‐0.0159,	  
0.0093	   -­‐0.0202*	  
-­‐0.0359,	  -­‐












<=22.5	   -­‐0.02579	  
-­‐0.062,	  
0.010	   -­‐0.0003	  
-­‐0.0163,	  
0.0157	   0.0005	  
-­‐0.0224,	  
0.0234	   0.0092	  
-­‐0.0212,	  
0.0396	  	   -­‐0.0403	  
-­‐0.0937,	  






<=23	   -­‐0.00603	  
-­‐0.040,	  
0.028	   0.009	  
-­‐0.0073,	  
0.0253	   0.0056	  
-­‐0.0163,	  
0.0276	   -­‐0.003	  
-­‐0.0305,	  
0.0245	   -­‐0.0204	  
-­‐0.0729,	  
0.0320	   -­‐0.0565	  
-­‐0.1478,	  
0.0347	  































<=26.25	   -­‐0.06321	  *	  
-­‐0.116,	  -­‐
0.010	   0.0155	  
-­‐0.0139,	  
0.0449	   -­‐0.0108	  
-­‐0.0393,	  
0.0177	   -­‐0.0243	  
-­‐0.0593,	  
0.0108	   -­‐0.0897	  
-­‐0.1449,	  -­‐






<=27	   -­‐0.03812	  *	  
-­‐0.070,	  -­‐
0.006	   -­‐0.0016	  
-­‐0.0183,	  
0.0150	   -­‐0.014	  
-­‐0.0323,	  












27	   Reference	   	  	   Reference	   	  	   Reference	   	  	   Reference	   	  	   Reference	   	  	   Reference	   	  	  
Note:	  weekday	  mid-­‐sleep	  time	  is	  calculate	  by	  dividing	  weekday	  sleep	  duration	  by	  two	  AND	  adding	  it	  to	  weekday	  bedtime;	  OLS	  and	  QR	  models	  adjusted	  for	  time	  of	  day	  pre-­‐interview	  sample	  collected,	  sex,	  age	  (linear,	  quadratic)	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TABLE 3B.  QUANTILE COEFFICIENT ESTIMATES (95% CI) FOR SELECTED QUANTILES, RATE OF CHANGE IN CORTISOL 
MEASUREMENTS BY HEALTH RELATED VARIABLES 
	  	   	  	   OLS	   Quantile	  Coefficient	  (95%	  CI)	  
	  	   	  	   β	   95%	  CI	   0.1	   95%	  CI	   0.25	   95%	  CI	   0.5	   95%	  CI	   0.75	   95%	  CI	   0.9	   95%	  CI	  






0.0180	  	   0.0083**	  
0.0022,	  
0.0144	   0.0135**	  
0.0043,	  
0.0227	   0.0158**	  
0.0043,	  
0.0272	   0.0193	  
-­‐0.0100,	  
0.0485	  




<=7hrs	   -­‐0.0023	  
-­‐0.017,	  
0.012	   0.0056a	  
-­‐0.0002,	  
0.0114	   0.0037	  
-­‐0.0011,	  
0.0085	   0.0059*	  
0.0003,	  
0.0114	   0.0085*	  
0.0019,	  






<=8hrs	   -­‐0.0025	  
-­‐0.016,	  
0.011	   0.0005	  
-­‐0.0050,	  
0.0061	   -­‐0.0009	  
-­‐0.0056,	  
0.0039	   0	  
-­‐0.0052,	  
0.0052	   0.0034	  
-­‐0.0033,	  





<=8.5hrs	   -­‐0.0071	  
-­‐0.031,	  
0.016	   -­‐0.0010	  
-­‐0.0130,	  
0.0110	   0.0009	  
-­‐0.0092,	  
0.0110	   0.0027	  
-­‐0.0078,	  
0.0132	   0.0099	  
-­‐0.0025,	  
























0.0058	   -­‐0.0098*	  
-­‐0.0172,	  -­‐






<=22.5	   0.0095	  
-­‐0.009,	  
0.028	   -­‐0.0046	  
-­‐0.0132,	  
0.0040	   -­‐0.0039	  
-­‐0.0111,	  
0.0033	   -­‐0.0074*	  
-­‐0.0146,	  -­‐
0.0002	   -­‐0.0031	  
-­‐0.0133,	  





<=23	   -­‐0.0061	  
-­‐0.023,	  
0.011	   -­‐0.0014	  
-­‐0.0089,	  
0.0061	   -­‐0.0024	  
-­‐0.0093,	  
0.0046	   -­‐0.006	  
-­‐0.0132,	  
0.0012	   -­‐0.009*	  
-­‐0.0167,	  -­‐
0.0013	   -­‐0.0094	  
-­‐0.0276,	  
0.0088	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4th	  Quartile:	  




<=26	   0.0129	  
-­‐0.003,	  
0.029	   -­‐0.0071*	  
-­‐0.0134,	  -­‐
0.0008	   -­‐0.0067*	  
-­‐0.0133,	  -­‐
0.0001	   -­‐0.0089**	  
-­‐0.0152,	  -­‐
0.0027	   -­‐0.0109*	  
-­‐0.0201,	  -­‐






<=26.25	   0.0139	  
-­‐0.013,	  
0.041	   -­‐0.0118*	  
-­‐0.0229,	  -­‐
0.0006	   -­‐0.0054	  
-­‐0.0175,	  
0.0067	   -­‐0.0008	  
-­‐0.0150,	  
0.0135	   -­‐0.0025	  
-­‐0.0180,	  





<=27	   0.0086	  
-­‐0.007,	  
0.025	   -­‐0.001	  
-­‐0.0081,	  
0.0061	  	   -­‐0.0036	  
-­‐0.0101,	  
0.0029	   -­‐0.0053	  
-­‐0.0117,	  
0.0012	   -­‐0.0081a	  
-­‐0.0162,	  





>	  27	   Reference	   	  	   Reference	   	  	   Reference	   	  	   Reference	   	  	   Reference	   	  	   Reference	   	  	  
Note:	  weekday	  mid-­‐sleep	  time	  is	  calculate	  by	  dividing	  weekday	  sleep	  duration	  by	  two	  AND	  adding	  it	  to	  weekday	  bedtime;	  OLS	  and	  QR	  models	  adjusted	  for	  pre-­‐interview	  sample	  collected,	  sex,	  age	  (linear,	  quadratic)	  and	  
pre-­‐interview	  cortisol	  level	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TABLE 4A.  QUANTILE COEFFICIENT ESTIMATES (95% CI) FOR SELECTED QUANTILES, PRE-INTERVIEW CORTISOL 
MEASUREMENTS BY DISORDER STATUS 
	  	   	  	   OLS	   Quantile	  Coefficient	  (95%	  CI)	  
	  	   	  	   β	   95%	  CI	   0.1	   95%	  CI	   0.25	   95%	  CI	   0.5	   95%	  CI	   0.75	   95%	  CI	   0.9	   95%	  CI	  
Mood	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
	  	  
1:	  	  12-­‐m	  
severe	  dx	   0.0190	  
-­‐0.055,	  
0.093	   0.0053	  
-­‐0.03995,	  
0.0505	   -­‐0.0014	  
-­‐0.0536,	  
0.0508	   0.0188	  
-­‐0.1010,	  
0.1385	   0.0703	  
-­‐0.0415,	  
0.1822	   0.0969	  
-­‐0.1155,	  
0.3092	  
	  	   2:	  	  12-­‐m	  dx	   0.0325	  
-­‐0.015,	  
0.080	   0.0169	  
-­‐0.0054,	  
0.0392	   0.0162	  
-­‐0.0070,	  
0.0395	   -­‐0.0196	  
-­‐0.0509,	  
0.0117	   0.0571	  
-­‐0.0359,	  
0.1502	   0.0703	  
-­‐0.0568,	  
0.1973	  




0.002	   -­‐0.0328**	  
-­‐0.0558,	  -­‐
0.0098	   -­‐0.0353*	  
-­‐0.0675,	  -­‐
0.0032	   -­‐0.045a	  
-­‐0.0902,	  
0.0002	   -­‐0.0497	  
-­‐0.1308,	  




4:	  	  Lifetime	  
other	  dx	   0.02114a	  
-­‐0.002,	  
0.045	   -­‐0.0007	  
-­‐0.0098,	  
0.0084	   -­‐0.0057	  
-­‐0.0170,	  
0.0057	   0.0100	  
-­‐0.0070,	  
0.0270	   0.0310	  
-­‐0.0104,	  
0.0724	   0.0513	  
-­‐0.0156,	  
0.1183	  
	  	   5:	  	  No	  dx	   Reference	   	  	   Reference	   	  	   Reference	   	  	   Reference	   	  	   Reference	   	  	   Reference	   	  	  
Anxiety	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
	  	  
1:	  	  12-­‐m	  
severe	  dx	   0.0251	  
-­‐0.024,	  
0.074	   -­‐0.0046	  
-­‐0.0265,	  
0.0174	   -­‐0.0096	  
-­‐0.0346,	  
0.0154	   -­‐0.0255	  
-­‐0.0733,	  
0.0223	   0.0707	  
-­‐0.0457,	  
0.1871	   0.1278a	  
-­‐0.0140,	  
0.2695	  
	  	   2:	  	  12-­‐m	  dx	   0.0268	  
-­‐0.006,	  
0.060	   -­‐0.0022	  
-­‐0.0165,	  
0.0122	   -­‐0.0092	  
-­‐0.0265,	  
0.0081	   -­‐0.0002	  
-­‐0.0216,	  
0.0212	   0.0052	  
-­‐0.0660,	  
0.0764	   0.1029a	  
-­‐0.0118,	  
0.2176	  
	  	   3:	  	  Lifetime	  dx	   0.04268a	  
-­‐0.002,	  
0.087	   0.0084	  
-­‐0.0176,	  
0.0344	   0.0150	  
-­‐0.0110,	  
0.0410	   0.0270	  
-­‐0.0188,	  
0.0728	   0.0550	  
-­‐0.0180,	  
0.1280	   0.0499	  
-­‐0.0743,	  
0.1742	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4:	  	  Lifetime	  
other	  dx	   -­‐0.00575	  
-­‐0.034,	  
0.023	   0.0008	  
-­‐0.0125,	  
0.0141	   -­‐0.0098	  
-­‐0.0240,	  
0.0045	   0.0038	  
-­‐0.0217,	  
0.0293	   0.0058	  
-­‐0.0419,	  
0.0536	   -­‐0.0059	  
-­‐0.0688,	  
0.0569	  
	  	   5:	  	  No	  dx	   Reference	   	  	   Reference	   	  	   Reference	   	  	   Reference	   	  	   Reference	   	  	   Reference	   	  	  
Note:	  OLS	  and	  Quantile	  regression	  models	  were	  adjusted	  for	  time	  of	  day	  cortisol	  sample	  collected,	  sex,	  age	  (linear,	  quadratic)	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TABLE 4B.  QUANTILE COEFFICIENT ESTIMATES (95% CI) FOR SELECTED QUANTILES, RATE OF CHANGE IN CORTISOL 
MEASUREMENTS BY DISORDER STATUS 
	  	   	  	   OLS	   Quantile	  Coefficient	  (95%	  CI)	  
	  	   	  	   β	   95%	  CI	   0.1	   95%	  CI	   0.25	   95%	  CI	   0.5	   95%	  CI	   0.75	   95%	  CI	   0.9	   95%	  CI	  
Mood	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
	  	  
1:	  	  12-­‐m	  
severe	  dx	   -­‐0.0020	  
-­‐0.039,	  
0.035	   0.0207a	  
-­‐0.0009,	  
0.0423	   0.0119*	  
0.0025,	  
0.0212	   0.0052	  
-­‐0.0083,	  
0.0188	   0.0021	  
-­‐0.0161,	  
0.0204	   -­‐0.0116	  
-­‐0.0491,	  
0.0258	  
	  	   2:	  	  12-­‐m	  dx	   -­‐0.0038	  
-­‐0.028,	  
0.020	   0.0138**	  
0.0040,	  
0.0237	   0.0171****	  
0.0091,	  
0.0251	   0.0138**	  
0.0039,	  
0.0237	   0.0105a	  
-­‐0.0011,	  




3:	  	  Lifetime	  
dx	   0.0276	  
-­‐0.001,	  
0.056	   0.0030	  
-­‐0.0059,	  
0.0119	   0.0083	  
-­‐0.0017,	  
0.0184	   0.0070	  
-­‐0.0020,	  
0.0160	   -­‐0.0024	  
-­‐0.0213,	  




4:	  	  Lifetime	  
other	  dx	   -­‐0.0065	  
-­‐0.018,	  
0.005	   0.0064**	  
0.0017,	  






0.0137	   0.0022	  
-­‐0.0032,	  
0.0076	   -­‐0.0071	  
-­‐0.0186,	  
0.0044	  
	  	   5:	  	  No	  dx	   Reference	   	  	   Reference	   	  	   Reference	   	  	   Reference	   	  	   Reference	   	  	   Reference	   	  	  
Anxiety	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
	  	  
1:	  	  12-­‐m	  
severe	  dx	   0.0025	  
-­‐0.022,	  
0.027	   0.0115a	  
-­‐0.0021,	  
0.0250	   0.0094a	  
-­‐0.0002,	  
0.0190	   0.0164**	  
0.0048,	  
0.0279	   0.012*	  
0.0009,	  
0.0231	   0.0034	  
-­‐0.0312,	  
0.0380	  
	  	   2:	  	  12-­‐m	  dx	   -­‐0.0090	  
-­‐0.026,	  
0.008	   0.0072*	  
0.0006,	  
0.0137	   0.0107***	  
0.0049,	  
0.0164	   0.0087**	  
0.0032,	  
0.0142	   0.0017	  
-­‐0.0056,	  




3:	  	  Lifetime	  
dx	   -­‐0.0061	  
-­‐0.028,	  
0.016	   0.0103*	  
0.0011,	  
0.0194	   0.0097*	  
0.0023,	  
0.0171	   0.0111**	  
0.0031,	  
0.0191	   0.0056	  
-­‐0.0083,	  
0.0194	   0.0031	  
-­‐0.0297,	  
0.0359	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4:	  	  Lifetime	  
other	  dx	   0.0011	  
-­‐0.013,	  
0.016	   0.0062*	  
0.0002,	  
0.0122	   0.0095****	  
0.0047,	  
0.0143	   0.0081**	  
0.0022,	  
0.0139	   -­‐0.0004	  
-­‐0.0072,	  
0.0064	   -­‐0.0106a	  
-­‐0.0230,	  
0.0019	  
	  	   5:	  	  No	  dx	   Reference	   	  	   Reference	   	  	   Reference	   	  	   Reference	   	  	   Reference	   	  	   Reference	   	  	  
NOTE:	  Rate	  of	  change	  in	  cortisol	  =	  post-­‐interview	  cortisol	  measure	  minus	  post-­‐interview	  cortisol	  measure	  divided	  by	  interview	  length	  in	  hours;	  	  OLS	  and	  Quantile	  regression	  models	  were	  adjusted	  for	  time	  of	  day	  pre-­‐interview	  
cortisol	  sample	  collected,	  sex,	  age	  (linear,	  quadratic),	  and	  pre-­‐interview	  cortisol	  measurements	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FIGURES 
	  
FIGURE 1. MEAN SALIVARY CORTISOL MEASURES BY TIME OF DAY SAMPLE COLLECTED 
	  
*	  Rate	  of	  change	  was	  calculated	  using	  post-­‐interview	  cortisol	  level	  minus	  pre-­‐interview	  cortisol	  level	  divided	  by	  interview	  length	  in	  hours.	  The	  time	  of	  day	  for	  pre-­‐interview	  salivary	  sample	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Figure 2a. Pre-interview cortisol quantile values by time of day
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FIGURE 2B: RATE OF CHANGE IN CORTISOL QUANTILE BY TIME OF DAY 
 
*(Rate	  of	  change	  =	  post	  minus	  pre-­‐interview	  cortisol	  divided	  by	  length	  of	  interview	  in	  hours)	  QR	  processing	  plot	  adjusting	  for	  pre-­‐interview	  cortisol	  level:	  	  8am-­‐<11am	  (Reference,	  zero	  
line),	  startT4catR	  1:	  11am-­‐<2pm,	  startT4catR	  2:	  	  2pm-­‐<5pm,	  startT4catR	  3:	  	  	  >=5pm)	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